Di Renzo Regulatory Affairs is a leading regulatory consulting firm with over 40 years of experience.
The services offered include medicinal products for human and veterinary use, medical devices, dietary supplements, cosmetics, biocides, medical and surgical devices, and related products.
It also has units dedicated to pharmacovigilance, medical device vigilance, cosmetovigilance, scientific information, quality management systems, and many other aspects of regulatory management.
With a strong international organization, the firm collaborates with numerous regulatory consultants in each European country and major non-European countries.
With the considerable expertise gained over the years and an organization comprised of numerous experts with degrees and medical and scientific training, Di Renzo Regulatory Affairs is able to offer appropriate and timely guidance, regulatory strategies, and services in each of the aforementioned areas of interest.

Medicines for Human Use
Our services for human medicines

Veterinary Medicines
Our services for human and veterinary medicines

Medical Devices
Our consultancy for manufacturers and distributors

PMC and Biocides
Services for PMC and Biocide manufacturing companies

Cosmetics
Our experts at the service of cosmetic companies

Food Supplements
Consulting for manufacturing and importing companies
Di Renzo Regulatory Affairs began operations in 1985 and has developed its organization to international standards over time. The company’s numerous experts hold degrees in scientific disciplines: chemistry, medicine, pharmacy, chemistry and pharmaceutical technology, engineering, biology, biotechnology, statistics, and more.
In 2019, Di Renzo Regulatory Affairs moved to a new operational headquarters, still located in Rome, but larger and more appropriate for its numerous and complex activities. The headquarters is close to the Ministry of Health, the AIFA (Italian Medicines Agency), and the National Institute of Health.
Di Renzo Regulatory Affairs also has two other offices, one in Milan and the other in London.

Open Job Positions
Send us your CV

Packaging Regulation 2025/40 (Ppwr): The Implications For Drugs, Medical Devices, Ivds, Cosmetics, Food Supplements And Foods For Specific Groups (Fsg)
Introduction to the PPWR With the adoption of Regulation (EU) 2025/40 of the European Parliament and of the Council on the Packaging and Packaging Waste (PPWR), the European Union has

Serialization of Italian Drugs: What changed?
With the Legislative Decree no. 10 of 6 February 2025 Italy has adopted Directive 2011/62/EU establishing that, as of 9 February 2027 all packs of drugs falling into the field

Medical Devices and IVD in Spain: introduction to the RECOPS database
On 27 May 2026, the obligation of notification into the Spanish database CCPS (Comunicación de comercialización de Productos Sanitarios) ceased to apply. The CCPS database was instituted by the Spanish